Business Description
Guangdong Zhongsheng Pharmaceutical Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE100000HW4
Share Class Description:
SZSE:002317: Class ACompare
Compare
Traded in other countries / regions
002317.China IPO Date
2009-12-11Description
Guangdong Zhongsheng Pharmaceutical Co Ltd is engaged in the pharmaceutical business. It isĀ involved in the research and development, production and sales of pharmaceuticals, the cultivation of medicinal materials, and the processing of medicinal herbs, chemical raw material synthesis, and pharmaceutical trade.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 717.69 | |||||
| Equity-to-Asset | 0.75 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Interest Coverage | 6.38 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 6.09 | |||||
| Beneish M-Score | -2.38 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.4 | |||||
| 3-Year FCF Growth Rate | -122.8 | |||||
| 3-Year Book Growth Rate | 5.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 13.85 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 14.23 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.66 | |||||
| 9-Day RSI | 36.18 | |||||
| 14-Day RSI | 38.25 | |||||
| 3-1 Month Momentum % | 1.31 | |||||
| 6-1 Month Momentum % | 9.97 | |||||
| 12-1 Month Momentum % | -13.94 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.79 | |||||
| Quick Ratio | 6.64 | |||||
| Cash Ratio | 3.29 | |||||
| Days Inventory | 168.9 | |||||
| Days Sales Outstanding | 79.72 | |||||
| Days Payable | 36.91 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.75 | |||||
| Dividend Payout Ratio | 1.08 | |||||
| Forward Dividend Yield % | 1.75 | |||||
| 5-Year Yield-on-Cost % | 1.89 | |||||
| 3-Year Average Share Buyback Ratio | -1.6 | |||||
| Shareholder Yield % | 5.68 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.12 | |||||
| Operating Margin % | 9.09 | |||||
| Net Margin % | 5.42 | |||||
| FCF Margin % | 8.93 | |||||
| ROE % | 3.04 | |||||
| ROA % | 2.16 | |||||
| ROIC % | 3.83 | |||||
| 3-Year ROIIC % | -3.22 | |||||
| ROC (Joel Greenblatt) % | 10.49 | |||||
| ROCE % | 3.37 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 71.25 | |||||
| Forward PE Ratio | 26.51 | |||||
| PE Ratio without NRI | 61.62 | |||||
| Shiller PE Ratio | 32.57 | |||||
| PS Ratio | 3.89 | |||||
| PB Ratio | 2.21 | |||||
| Price-to-Tangible-Book | 3.11 | |||||
| Price-to-Free-Cash-Flow | 45.39 | |||||
| Price-to-Operating-Cash-Flow | 22.16 | |||||
| EV-to-EBIT | 46.63 | |||||
| EV-to-EBITDA | 46.63 | |||||
| EV-to-Revenue | 3.47 | |||||
| EV-to-FCF | 39.7 | |||||
| Price-to-GF-Value | 0.64 | |||||
| Price-to-Projected-FCF | 1.98 | |||||
| Price-to-Median-PS-Value | 0.79 | |||||
| Price-to-Graham-Number | 2.92 | |||||
| Price-to-Net-Current-Asset-Value | 5.33 | |||||
| Earnings Yield (Greenblatt) % | 2.14 | |||||
| FCF Yield % | 2.25 | |||||
| Forward Rate of Return (Yacktman) % | -0.41 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Ā
Total Annual Return % Ā
Guangdong Zhongsheng Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil Ā„) | 2,447.294 | ||
| EPS (TTM) (Ā„) | 0.16 | ||
| Beta | 1.53 | ||
| 3-Year Sharpe Ratio | 0.27 | ||
| 3-Year Sortino Ratio | 0.6 | ||
| Volatility % | 57.09 | ||
| 14-Day RSI | 38.25 | ||
| 14-Day ATR (Ā„) | 0.426365 | ||
| 20-Day SMA (Ā„) | 12.0295 | ||
| 12-1 Month Momentum % | -13.94 | ||
| 52-Week Range (Ā„) | 10.22 - 18.42 | ||
| Shares Outstanding (Mil) | 851.56 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Guangdong Zhongsheng Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Guangdong Zhongsheng Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (Ā„) | ||
|---|---|---|---|---|
| No Event Data | ||||
Guangdong Zhongsheng Pharmaceutical Co Ltd Frequently Asked Questions
What is Guangdong Zhongsheng Pharmaceutical Co Ltd(SZSE:002317)'s stock price today?
The current price of SZSE:002317 is Ā„11.40. The 52 week high of SZSE:002317 is Ā„18.42 and 52 week low is Ā„10.22.
When is next earnings date of Guangdong Zhongsheng Pharmaceutical Co Ltd(SZSE:002317)?
The next earnings date of Guangdong Zhongsheng Pharmaceutical Co Ltd(SZSE:002317) is .
Does Guangdong Zhongsheng Pharmaceutical Co Ltd(SZSE:002317) pay dividends? If so, how much?
TheĀ Dividend Yield % Ā of Guangdong Zhongsheng Pharmaceutical Co Ltd(SZSE:002317) is 1.75% (As of Today), HighestĀ Dividend Payout RatioĀ of Guangdong Zhongsheng Pharmaceutical Co Ltd(SZSE:002317) was 1.08. The lowest was 0.28. And the median was 0.54. The Ā Forward Dividend Yield % of Guangdong Zhongsheng Pharmaceutical Co Ltd(SZSE:002317) is 1.75%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers